Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.
Clinical trial NCT04519476 · UNKNOWN
Trial details
- NCT number
- NCT04519476
- Sponsor
- Oncotherapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2023-12-29
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.